These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 36607951

  • 1. Long Noncoding RNA PSMA3 Antisense RNA 1 Promotes Cell Proliferation, Migration, and Invasion in Pancreatic Ductal Adenocarcinoma Via Targeting MicroRNA-154-5p to Positively Modulate Karyopherin Subunit Alpha 4.
    Bi J, Liang W, Wang Y, Tian W, Cao S, Liu P.
    Pancreas; 2022 Sep 01; 51(8):1037-1046. PubMed ID: 36607951
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. lncRNA PSMA3-AS1 promotes the progression of non-small cell lung cancer through targeting miR-17-5p/PD-L1.
    Cheng G, Li Y, Liu Z, Song X.
    Adv Clin Exp Med; 2021 Oct 01; 30(10):1043-1050. PubMed ID: 34610219
    [Abstract] [Full Text] [Related]

  • 4. YY1-induced long non-coding RNA PSMA3 antisense RNA 1 functions as a competing endogenous RNA for microRNA 214-5p to expedite the viability and restrict the apoptosis of bladder cancer cells via regulating programmed cell death-ligand 1.
    Zhang M, Xu Y, Yin S, Qiu F.
    Bioengineered; 2021 Dec 01; 12(2):9150-9161. PubMed ID: 34720049
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Targeting lncRNA PSMA3-AS1, a Prognostic Marker, Suppresses Malignant Progression of Oral Squamous Cell Carcinoma.
    Cao X, Luan K, Yang J, Huang Y.
    Dis Markers; 2021 Dec 01; 2021():3138046. PubMed ID: 34457087
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long non-coding RNA PSMA3-AS1 promotes glioma progression through modulating the miR-411-3p/HOXA10 pathway.
    Huang T, Chen Y, Zeng Y, Xu C, Huang J, Hu W, Chen X, Fu H.
    BMC Cancer; 2021 Jul 22; 21(1):844. PubMed ID: 34294084
    [Abstract] [Full Text] [Related]

  • 13. Long non-coding RNA PSMA3-AS1 promotes malignant phenotypes of esophageal cancer by modulating the miR-101/EZH2 axis as a ceRNA.
    Qiu BQ, Lin XH, Ye XD, Huang W, Pei X, Xiong D, Long X, Zhu SQ, Lu F, Lin K, Zhang XQ, Xu JJ, Sheng LL, Zhang XM, Zhang PF, Wu YB.
    Aging (Albany NY); 2020 Jan 31; 12(2):1843-1856. PubMed ID: 32005028
    [Abstract] [Full Text] [Related]

  • 14. lncRNA THAP9-AS1 Promotes Pancreatic Ductal Adenocarcinoma Growth and Leads to a Poor Clinical Outcome via Sponging miR-484 and Interacting with YAP.
    Li N, Yang G, Luo L, Ling L, Wang X, Shi L, Lan J, Jia X, Zhang Q, Long Z, Liu J, Hu W, He Z, Liu H, Liu W, Zheng G.
    Clin Cancer Res; 2020 Apr 01; 26(7):1736-1748. PubMed ID: 31831555
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. LncRNA PSMA3-AS1 promotes preterm delivery by inducing ferroptosis via miR-224-3p/Nrf2 axis.
    Qiu L, Lin X, Chen R, Wu Y, Yan J.
    Cell Mol Biol (Noisy-le-grand); 2023 Dec 10; 69(13):270-278. PubMed ID: 38158666
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S, Yu W, Lin S, Zhang M, Wang T, Guo S, Wang H.
    Cancer Biol Ther; 2018 Jul 03; 19(7):573-583. PubMed ID: 29667486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.